Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
JUNTENDO, Mar-Nov (Cumulative 3Q) Ordinary Profit Increases by 39%, Exceeds Full-Year Plan
9835 JUNTENDO CO.,LTD. 【J-GAAP】
Earnings ReportJUNTENDO CO.,LTD. <9835> [TSE Std] announced its financial results after the market closed on January 10th (15:30). The ordinary profit (non-consolidated) for the cumulative third quarter of the fiscal year ending February 2025 (March to November) expanded 730 million yen, an increase 38.5% compared to the same period last year. The progress rate toward the full-year plan of 300 million yen is 243.3%, already exceeding the target and also exceeding the five-year average of 139.6%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the ordinary loss for the December to February period (4Q) is expected to expand to a loss of 430 million yen (compared to a loss of 210 million yen in the same period last year).
In the most recent three-month period, from September to November (3Q), the ordinary profit/loss turned to a loss of 111 million yen (compared to a profit of 25 million yen in the same period last year). The operating profit/loss margin worsened from 0.3% in the same period last year to -1.0%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar - Nov, 2022 | 34,441 | 1,122 | 1,130 | 741 | 91.4 | 122.6 | Jan 10, 2023 | J-GAAP |
Mar - Nov, 2023 | 34,640 | 528 | 527 | 366 | 45.1 | 166.2 | Jan 10, 2024 | J-GAAP |
Mar - Nov, 2024 | 34,221 | 738 | 730 | 436 | 53.8 | 243.3 | Jan 10, 2025 | J-GAAP |
YoY | -1.2% | +39.8% | +38.5% | +19.1% | +19.2% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Sep - Feb, 2023 | 21,025 | -180 | -185 | -93 | -11.5 | 10 | Apr 12, 2024 | J-GAAP |
Sep - Feb, 2024 Guidance | 21,726 | -495 | -541 | -458 | -56.5 | 10 | Oct 11, 2024 | J-GAAP |
YoY | +3.3% | -175.0% | -192.4% | -392.5% | -390.2% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Feb, 2023 | 44,964 | 906 | 922 | 382 | 47.2 | 15 | Apr 12, 2023 | J-GAAP |
Feb, 2024 | 44,653 | 319 | 317 | 188 | 23.3 | 10 | Apr 12, 2024 | J-GAAP |
Feb, 2025 Guidance | 45,300 | 350 | 300 | 100 | 12.3 | 10 | Apr 12, 2024 | J-GAAP |
YoY | +1.4% | +9.7% | -5.4% | -46.8% | -47.1% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Sep - Nov, 2023 | 11,012 | 29 | 25 | 85 | 10.5 | 0.3 | Jan 10, 2024 | J-GAAP |
Dec - Feb, 2023 | 10,013 | -209 | -210 | -178 | -22.1 | -2.1 | Apr 12, 2024 | J-GAAP |
Mar - May, 2024 | 12,218 | 479 | 475 | 310 | 38.3 | 3.9 | Jul 9, 2024 | J-GAAP |
Jun - Aug, 2024 | 11,356 | 366 | 366 | 248 | 30.6 | 3.2 | Oct 11, 2024 | J-GAAP |
Sep - Nov, 2024 | 10,647 | -107 | -111 | -122 | -15.1 | -1.0 | Jan 10, 2025 | J-GAAP |
YoY | -3.3% | - | - | - | - |
Related Articles
STrust, Mar-Nov (Cumulative 3Q) Ordinary Profit Increases by 8.0 times, Sep-Nov Ordinary Profit Increases by 91%
RORZE, Sep-Nov (3Q) Ordinary Profit Decreases by 17%
Bewith Inc, The Current Fiscal Year Ordinary Profit Revised Downward to an Unexpected 43% Decrease
Shirohato, Mar-Nov (Cumulative 3Q) Ordinary Profit Loss Narrows, Sep-Nov Ordinary Profit Turns to Profit
Medical Ikkou, Sep-Nov (3Q) Ordinary Profit Decreases by 14%
KURAUDIA HOLDINGS, Sep-Nov (1Q) Ordinary Profit Decreases by 23%, Exceeds Full-Year Plan
TOYO ASANO FOUNDATION, Mar-Nov (Cumulative 3Q) Ordinary Profit Decreases by 62%, Sep-Nov Ordinary Profit Turns to Loss
Maxvalu Tokai, Mar-Nov (Cumulative 3Q) Ordinary Profit Increases by 2%
STUDIO ALICE, Mar-Nov (Cumulative 3Q) Ordinary Profit Increases by 22%, Sep-Nov Ordinary Profit Increases by 8%
COSMOS Pharma, First Half Ordinary Profit Increases by 26%